Therapy for hyperglycemia, related disorders and erectile dysfunction
A technology for fatty acid oxidation and hyperglycemia, which is applied in the field of fatty acid oxidation inhibitors for the treatment of hyperglycemia and related diseases, and can solve the problem that the therapy is not suitable for patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0043]Existing first-line therapies for the treatment of hyperglycemia and T2DM focus on lowering glucose levels (eg, as predicted by a reduction in %HbA1c). Since patients with hyperglycemia and T2DM are at increased risk of morbidity and mortality due to life-threatening sequelae such as T2DM-related cardiovascular disease, retinopathy, nephropathy, and neuropathy, reduction of the risk of this disease may be sought after administration of glucose-lowering therapy adjunctive therapy (eg, lipid-lowering agents, antihypertensives, antianginal agents). Addition of adjuvant therapy may reduce morbidity and mortality in patients with hyperglycemia or T2DM due to, for example, cardiovascular disease. However, other than its effect on hyperglycemia, there is currently no first-line therapy that effectively lowers glucose levels and also reduces the occurrence of life-threatening sequelae of hyperglycemia and T2DM, or reduces - associated cardiovascular disease, retinopathy, nephro...
PUM

Abstract
Description
Claims
Application Information

- Generate Ideas
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com